CB

Chiara Bergerone

Director Director DIN 10240183
DIN 10240183 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2023
Shareholding value •••• Premium profile

About Chiara Bergerone

Data last updated:

Chiara Bergerone was a Director at Monolom India Pharma Private Limited (2023–2024) and Director at Vanamali Organics Private Limited (2023–2024). The companies operate in Pharma and Chemicals and Materials.

DIN 10240183
Primary Designation Director
Industry Pharma
First Appointment 19 Jul 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Monolom India Pharma Private Limited U24303PN2017FTC188118
Director27 Sep 20232017₹18.17 Cr (FY 2025)Active
Vanamali Organics Private Limited U24232TG2013PTC086144
Director19 Jul 20232013₹79.39 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Monolom India Pharma Private Limited
Vanamali Organics Private Limited
Premium access

Shareholding and investment profile for Chiara Bergerone

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chiara Bergerone

Chiara Bergerone was first appointed on 19 Jul 2023 as Director at Vanamali Organics Private Limited.

Chiara Bergerone held 2 earlier board appointments: Monolom India Pharma Private Limited (Director, 27 Sep 2023 to 05 Dec 2024); Vanamali Organics Private Limited (Director, 19 Jul 2023 to 05 Dec 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available